1988
DOI: 10.1177/003693308803300416
|View full text |Cite
|
Sign up to set email alerts
|

Does Non-Acetylated Salicylate Inhibit Thromboxane Biosynthesis in Human Platelets?

Abstract: Ingestion of aspirin (acetyl salicylic acid: ASA) may promote bleeding complications due to inhibition of thromboxane biosynthesis, which results in the prolongation of bleeding time. The effect is believed to be achieved by the irreversible acetylation of the enzyme cyclooxygenase by aspirin. This alteration in platelet function by aspirin prohibits its use in patients with bleeding disorders such as haemophiliacs. Choline magnesium trisalicylate (CMT; Napp Laboratories Ltd) is a non-acetylated salicylate wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1991
1991
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…4 Importantly, therapeutic benefit is not compromised by using choline magnesium trisalicylate in lieu of aspirin. Studies in adult patients have shown that serum salicylate concentrations and salicylates elimination rates are equivalent to those reported for aspirin.…”
Section: Discussionmentioning
confidence: 99%
“…4 Importantly, therapeutic benefit is not compromised by using choline magnesium trisalicylate in lieu of aspirin. Studies in adult patients have shown that serum salicylate concentrations and salicylates elimination rates are equivalent to those reported for aspirin.…”
Section: Discussionmentioning
confidence: 99%